Back to search

Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model

Data up to Jan 2025

Published1998
Citations59
References22

Total Citations Per Year

Abstract

References (22)

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

1996 • 4,580 citations

EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION

1981 • 1,087 citations

Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart Disease

1995 • 200 citations

Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium.

1987 • 190 citations

Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial Infarction

1997 • 160 citations

Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part II.

1997 • 126 citations

Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.

1993 • 125 citations

PH-Metric logP.4. Comparison of Partition Coefficients Determined by HPLC and Potentiometric Methods to Literature Values

1994 • 123 citations

Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper

1992 • 90 citations

Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.

1993 • 83 citations

Cardioprotective effects of carvedilol, a novel adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol

1992 • 81 citations

Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.

1996 • 80 citations

Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.

1990 • 76 citations

In vitro Pharmacologic Profile of the Novel Beta-Adrenoceptor Antagonist and Vasodilator, Carvedilol

1989 • 73 citations

Carvedilol update. 4: Prevention of oxidative stress, cardiac remodeling and progression of congestive heart failure

1997 • 50 citations

Carvedilol (Kredex®) Reduces Infarct Size in a Canine Model of Acute Myocardial Infarction

1991 • 48 citations

Recent advances in the identification of a 1- and a 2-adrenoceptor subtypes: therapeutic implications

1997 • 47 citations

Myocardial protection by the novel vasodilating beta-blocker, carvedilol

1993 • 41 citations

Carvedilol update III: Rationale for use in congestive heart failure

1995 • 34 citations

Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury

1996 • 33 citations

Carvedilol Protects Against Lethal Reperfusion Injury Through Antiadrenergic Mechanisms

1996 • 32 citations

Celiprolol

1995 • 15 citations

Cited By (0)

Loading...